At a glance
The January 25, 2021, Clinical Laboratory COVID-19 Response (CLCR) call included updates on clinical laboratory result abnormalities with COVID-19, SARS-CoV-2 variants, CMS billing, and an FDA update.
Agenda
Archived LOCS Materials Access
Welcome: Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
What Are the Clinical Laboratory Result Abnormalities in Patients Hospitalized with COVID-19?: Nadia Ayala-Lopez, Johns Hopkins Medical Institute
COVID-19 Variants and Surveillance: Chris Elkins, CDC COVID-19 Laboratory and Testing Task Force
CMS Billing Update: Sarah Harding, Centers for Medicare & Medicaid Services (CMS)
FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
The information on this page was last reviewed by subject matter experts to ensure accuracy.